Scientific article

Challenges, Progresses, and Promises for Developing Future NADPH Oxidase Therapeutics

Published inAntioxidants & redox signaling, vol. 23, no. 5, p. 355-357
Publication date2015

NADPH oxidase (NOX) enzymes show great potential as therapeutic pharmacological targets. This Forum revolves around the roles of specific NOX isoforms in oxidative stress-mediated pathologies, available NOX antagonists/agonists as well as the potential side effects of NOX inhibition and the requisite identification of novel oxidative biomarkers as a measure of NOX activity in patients. In addition, an original article reports the discovery of a novel small molecule NOX2 inhibitor. Finally an attractive and innovative therapeutic approach for modulating NOX activity through the inhibition of the proton channel Hv1 is discussed.

  • Animals
  • Drug Discovery
  • Humans
  • Ion Channels/metabolism
  • NADPH Oxidase/therapeutic use
  • Oxidative Stress
Citation (ISO format)
BEDARD, Karen, WHITEHOUSE, Scott, JAQUET, Vincent. Challenges, Progresses, and Promises for Developing Future NADPH Oxidase Therapeutics. In: Antioxidants & redox signaling, 2015, vol. 23, n° 5, p. 355–357. doi: 10.1089/ars.2015.6450
Main files (1)
Article (Published version)
ISSN of the journal1523-0864

Technical informations

Creation08/29/2016 4:43:00 PM
First validation08/29/2016 4:43:00 PM
Update time03/15/2023 2:12:26 PM
Status update03/15/2023 2:12:25 PM
Last indexation01/16/2024 9:55:54 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack